Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CX4-H5219 | Human | Human CXCR4 / CD184 Full Length Protein (VLP) |
|
||
CX4-H5269 | Human | Human CXCR4 / CD184 Protein, Fc Tag |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Plerixafor | SDZ-SID-791; JM-3100; JKL-169; AMD-3100; PLR-001; LM-3100 | Approved | Genzyme Corp | Mozobil, Mobozil, 释倍灵 | United States | Lymphoma, Non-Hodgkin; Multiple Myeloma | Genzyme Corp | 2008-12-15 | Lymphoma, Non-Hodgkin; Pulmonary Fibrosis; Rejection of organ transplantation; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukopenia; Colorectal Neoplasms; Agranulocytosis; Lymphopenia; Multiple Myeloma; Lymphoma; Leukemia, Myeloid, Acute; Pulmonary Disease, Chronic Obstructive; Granulomatous Disease, Chronic; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Anemia, Sickle Cell; Bone metastases; Fanconi Anemia; Pancreatic Neoplasms; Hodgkin Disease; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19); Primary Graft Dysfunction; Warts; WHIM syndrome; Neutropenia; Infections; Wiskott-Aldrich Syndrome; Cystic Fibrosis; Hematopoietic stem cell transplantation (HSCT); Leukemia, Myelogenous, Chronic; Hematologic Neoplasms | Details |
Motixafortide | TN-14003; TF-14016; BL-8040; 4F-Benzoyl-TN14003; BKT-140; GFH-168; 4F-benzoyl-TN-14003 | Approved | Biokine, Kyoto University | APHEXDA | United States | Hematopoietic stem cell transplantation (HSCT) | Biolinerx Ltd | 2023-09-08 | Multiple Myeloma; Anemia, Sickle Cell; Adenocarcinoma; Lymphoma, T-Cell; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Anemia, Aplastic; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Hematopoietic stem cell transplantation (HSCT); Myeloproliferative Disorders; Myelodysplastic Syndromes; Pancreatic Neoplasms; Hodgkin Disease; Esophageal Neoplasms; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic | Details |
Plerixafor | SDZ-SID-791; JM-3100; JKL-169; AMD-3100; PLR-001; LM-3100 | Approved | Genzyme Corp | Mozobil, Mobozil, 释倍灵 | United States | Lymphoma, Non-Hodgkin; Multiple Myeloma | Genzyme Corp | 2008-12-15 | Lymphoma, Non-Hodgkin; Pulmonary Fibrosis; Rejection of organ transplantation; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukopenia; Colorectal Neoplasms; Agranulocytosis; Lymphopenia; Multiple Myeloma; Lymphoma; Leukemia, Myeloid, Acute; Pulmonary Disease, Chronic Obstructive; Granulomatous Disease, Chronic; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Anemia, Sickle Cell; Bone metastases; Fanconi Anemia; Pancreatic Neoplasms; Hodgkin Disease; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19); Primary Graft Dysfunction; Warts; WHIM syndrome; Neutropenia; Infections; Wiskott-Aldrich Syndrome; Cystic Fibrosis; Hematopoietic stem cell transplantation (HSCT); Leukemia, Myelogenous, Chronic; Hematologic Neoplasms | Details |
Motixafortide | TN-14003; TF-14016; BL-8040; 4F-Benzoyl-TN14003; BKT-140; GFH-168; 4F-benzoyl-TN-14003 | Approved | Biokine, Kyoto University | APHEXDA | United States | Hematopoietic stem cell transplantation (HSCT) | Biolinerx Ltd | 2023-09-08 | Multiple Myeloma; Anemia, Sickle Cell; Adenocarcinoma; Lymphoma, T-Cell; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Anemia, Aplastic; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Hematopoietic stem cell transplantation (HSCT); Myeloproliferative Disorders; Myelodysplastic Syndromes; Pancreatic Neoplasms; Hodgkin Disease; Esophageal Neoplasms; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
[68Ga]Pentixafor | Phase 3 Clinical | The University Of Iowa | Lymphoma, B-Cell, Marginal Zone; Cushing Syndrome; Sarcoidosis; Rejection of organ transplantation; Neuroendocrine Tumors; Myocarditis; Central Nervous System Lymphoma; Hyperaldosteronism | Details | |
90Y-Pentixather | Phase 2 Clinical | University Of Wurzburg, Technical University Of Munich | Multiple Myeloma; Central Nervous System Lymphoma | Details | |
177Lu-Pentixather | Phase 2 Clinical | Technical University Of Munich, Nantes University Hospital, University Of Wurzburg | Leukemia; Multiple Myeloma | Details | |
Ulocuplumab | MDX-1338; BMS-936564 | Phase 2 Clinical | Bristol-Myers Squibb Company | Leukemia; Solid tumours; Multiple Myeloma; Lymphoma, Follicular; Leukemia, B-Cell; Waldenstrom Macroglobulinemia; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
MSX-122 | Q-122; WZ-40; MSX-122 | Phase 2 Clinical | Altiris Therapeutics | Solid tumours; Hot Flashes | Details |
PTX-9908 | PTX-9908 | Phase 2 Clinical | Pertinax Therapeutics | Carcinoma, Hepatocellular | Details |
Plerixafor/Tacrolimus Hydrate | MRG-001(MedRegen); AMD3100+FK506 | Phase 2 Clinical | MedRegen LLC | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Abdominal Injuries; Wounds and Injuries | Details |
NRP-2945 | NNZ-4945; NRP-2945 | Phase 2 Clinical | Neuren Pharmaceuticals Ltd | Epilepsy | Details |
GPC-100 | GPC-100 | Phase 2 Clinical | GPCR Therapeutics USA Inc | Multiple Myeloma | Details |
4-P-021 | 4P021; 4-P-021 | Phase 2 Clinical | 4P-Pharma Ltd, University of Bordeaux, Institut Pasteur De Lille | Coronavirus Disease 2019 (COVID-19) | Details |
CGT-1881 | CGT1881; CGT-1881 | Phase 2 Clinical | Cgenetech(Suzhou China) Co Ltd | Hematologic Neoplasms; Hematopoietic stem cell transplantation (HSCT); Multiple Myeloma; Lymphoma, Non-Hodgkin | Details |
LY-2510924 | T-134; LY-2510924 | Phase 1 Clinical | Eli Lilly And Company | Leukemia; Solid tumours; Carcinoma, Renal Cell; Small Cell Lung Carcinoma | Details |
AGT 103-T | AGT 103-T | Phase 1 Clinical | American Gene Technologies International Inc | HIV Infections | Details |
Balixafortide | POL-6326 | Phase 1 Clinical | Polyphor Ltd | Leukemia, Myelogenous, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders; Multiple Myeloma; Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
JVS-100 | JVS-100; SRX-100; ACRX-100; GP-51801; GP51801 | Phase 1 Clinical | Cleveland Clinic | Heart Failure; Ischemia; Surgical Wound; Peripheral Arterial Disease | Details |
Dociparstat sodium | ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 | Phase 1 Clinical | Paringenix | Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myelodysplastic Syndromes; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Leukemia, Myeloid, Acute; Acute Lung Injury | Details |
203-Lead Pentixather | Phase 1 Clinical | National Institutes Of Health, National Cancer Institute, Holden Comprehensive Cancer Center | Small Cell Lung Carcinoma; Lung Neoplasms | Details | |
212-Lead Pentixather | Phase 1 Clinical | National Institutes Of Health, National Cancer Institute, Holden Comprehensive Cancer Center | Small Cell Lung Carcinoma; Lung Neoplasms | Details | |
68Ga-Pentixather | 68Ga-Pentixather | Phase 1 Clinical | Peking Union Medical College Hospital | Multiple Myeloma | Details |
CXCR4 modified anti-BCMA CAR T cell therapy (Sichuan University) | Phase 1 Clinical | Sichuan University | Multiple Myeloma | Details | |
AD-214 | AD-214 | Phase 1 Clinical | Addpharma Inc, Adalta Ltd | Lung Diseases, Interstitial; Gastroesophageal Reflux | Details |
X-4136 | X-4136 | Clinical | X4 Pharmaceuticals Inc | Lymphoma, B-Cell; Uterine Cervical Neoplasms; Melanoma | Details |
[18F]AlF-NOTA-pentixather | Sichuan Provincial People'S Hospital | Details | |||
[68Ga]Pentixafor | Phase 3 Clinical | The University Of Iowa | Lymphoma, B-Cell, Marginal Zone; Cushing Syndrome; Sarcoidosis; Rejection of organ transplantation; Neuroendocrine Tumors; Myocarditis; Central Nervous System Lymphoma; Hyperaldosteronism | Details | |
90Y-Pentixather | Phase 2 Clinical | University Of Wurzburg, Technical University Of Munich | Multiple Myeloma; Central Nervous System Lymphoma | Details | |
177Lu-Pentixather | Phase 2 Clinical | Technical University Of Munich, Nantes University Hospital, University Of Wurzburg | Leukemia; Multiple Myeloma | Details | |
Ulocuplumab | MDX-1338; BMS-936564 | Phase 2 Clinical | Bristol-Myers Squibb Company | Leukemia; Solid tumours; Multiple Myeloma; Lymphoma, Follicular; Leukemia, B-Cell; Waldenstrom Macroglobulinemia; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
MSX-122 | Q-122; WZ-40; MSX-122 | Phase 2 Clinical | Altiris Therapeutics | Solid tumours; Hot Flashes | Details |
PTX-9908 | PTX-9908 | Phase 2 Clinical | Pertinax Therapeutics | Carcinoma, Hepatocellular | Details |
Plerixafor/Tacrolimus Hydrate | MRG-001(MedRegen); AMD3100+FK506 | Phase 2 Clinical | MedRegen LLC | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Abdominal Injuries; Wounds and Injuries | Details |
NRP-2945 | NNZ-4945; NRP-2945 | Phase 2 Clinical | Neuren Pharmaceuticals Ltd | Epilepsy | Details |
GPC-100 | GPC-100 | Phase 2 Clinical | GPCR Therapeutics USA Inc | Multiple Myeloma | Details |
4-P-021 | 4P021; 4-P-021 | Phase 2 Clinical | 4P-Pharma Ltd, University of Bordeaux, Institut Pasteur De Lille | Coronavirus Disease 2019 (COVID-19) | Details |
CGT-1881 | CGT1881; CGT-1881 | Phase 2 Clinical | Cgenetech(Suzhou China) Co Ltd | Hematologic Neoplasms; Hematopoietic stem cell transplantation (HSCT); Multiple Myeloma; Lymphoma, Non-Hodgkin | Details |
LY-2510924 | T-134; LY-2510924 | Phase 1 Clinical | Eli Lilly And Company | Leukemia; Solid tumours; Carcinoma, Renal Cell; Small Cell Lung Carcinoma | Details |
AGT 103-T | AGT 103-T | Phase 1 Clinical | American Gene Technologies International Inc | HIV Infections | Details |
Balixafortide | POL-6326 | Phase 1 Clinical | Polyphor Ltd | Leukemia, Myelogenous, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders; Multiple Myeloma; Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
JVS-100 | JVS-100; SRX-100; ACRX-100; GP-51801; GP51801 | Phase 1 Clinical | Cleveland Clinic | Heart Failure; Ischemia; Surgical Wound; Peripheral Arterial Disease | Details |
Dociparstat sodium | ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 | Phase 1 Clinical | Paringenix | Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myelodysplastic Syndromes; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Leukemia, Myeloid, Acute; Acute Lung Injury | Details |
203-Lead Pentixather | Phase 1 Clinical | National Institutes Of Health, National Cancer Institute, Holden Comprehensive Cancer Center | Small Cell Lung Carcinoma; Lung Neoplasms | Details | |
212-Lead Pentixather | Phase 1 Clinical | National Institutes Of Health, National Cancer Institute, Holden Comprehensive Cancer Center | Small Cell Lung Carcinoma; Lung Neoplasms | Details | |
68Ga-Pentixather | 68Ga-Pentixather | Phase 1 Clinical | Peking Union Medical College Hospital | Multiple Myeloma | Details |
CXCR4 modified anti-BCMA CAR T cell therapy (Sichuan University) | Phase 1 Clinical | Sichuan University | Multiple Myeloma | Details | |
AD-214 | AD-214 | Phase 1 Clinical | Addpharma Inc, Adalta Ltd | Lung Diseases, Interstitial; Gastroesophageal Reflux | Details |
X-4136 | X-4136 | Clinical | X4 Pharmaceuticals Inc | Lymphoma, B-Cell; Uterine Cervical Neoplasms; Melanoma | Details |
[18F]AlF-NOTA-pentixather | Sichuan Provincial People'S Hospital | Details |
This web search service is supported by Google Inc.